Benzimidazole nf- kappab inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 417/14 (2006.01) A61K 31/4436 (2006.01) A61K 31/4535 (2006.01) A61K 31/519 (2006.01) A61K 31/52 (2006.01) A61K 31/53 (2006.01) A61P 9/00 (2006.01) A61P 31/16 (2006.01) A61P 35/00 (2006.01) C07D 473/34 (2006.01) C07D 487/04 (2006.01) C07D 495/04 (2006.01)

Patent

CA 2699817

The present invention relates to compounds of the general formula (Ihb) or pharmaceutically acceptable salts thereof with an acid or a base or a stereoisomer thereof for the prevention and/or treatment of a disease associated with increased cytokine release, wherein Y' is O or NR2; Z is N or CR2'; X is NR2', O or S; R2' is H, alkyl, -C(O)NR7, -C(O)R e, cycloalkyl, haloalkyl, hydroxyalkyl, hydroxyalkylamino, alkylamino, heteroaryl, or aryl; R3 is H, methyl, ethyl, methoxy, amine, alkylamine, morpholino, N-methylpiperazine, CF3, or OCF3; R2a is substituted or unsubstituted aryl, benzyl or heteroaryl.

La présente invention concerne des composés de formule générale (Ihb) ou des sels pharmaceutiquement acceptables de ceux-ci avec un acide ou une base ou un stéréo-isomère de ceux-ci, ces composés étant destinés à la prévention et/ou au traitement d'une maladie liée à une libération accrue de cytokines. Dans la formule générale (Ihb), Y' représente O ou NR2'; Z représente N ou CR2'; X représente NR2', O ou S; R2' représente H, alkyle, -C(O)NR7, -C(O)Re, cycloalkyle, haloalkyle, hydroxyalkyle, hydroxyalkylamino, alkylamino, hétéroaryle ou aryle; R3 représente H, méthyle, éthyle, méthoxy, amine, alkylamine, morpholino, N-méthylpipérazine, CF3 ou OCF3; R2a représente un groupe aryle, benzyle ou hétéroaryle substitué ou non substitué.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Benzimidazole nf- kappab inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Benzimidazole nf- kappab inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzimidazole nf- kappab inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1471205

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.